SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001564590-22-017041
Filing Date
2022-05-02
Accepted
2022-05-02 16:01:23
Documents
15
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A scyx-10ka_20211231.htm   iXBRL 10-K/A 781596
2 EX-10.36 scyx-ex1036_43.htm EX-10.36 10480
3 EX-31.3 scyx-ex313_6.htm EX-31.3 5841
4 EX-31.4 scyx-ex314_7.htm EX-31.4 5881
  Complete submission text file 0001564590-22-017041.txt   1065673

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA scyx-20211231.xsd EX-101.SCH 5693
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE scyx-20211231_lab.xml EX-101.LAB 31170
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scyx-20211231_pre.xml EX-101.PRE 18736
9 EXTRACTED XBRL INSTANCE DOCUMENT scyx-10ka_20211231_htm.xml XML 8725
Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Filer) CIK: 0001178253 (see all company filings)

IRS No.: 562181648 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36365 | Film No.: 22881799
SIC: 2834 Pharmaceutical Preparations